What move does the options market price into Teva Pharmaceutical Industries's report?

Implied ±6.0%, either direction.

TEVANYSEManufacturing

Teva Pharmaceutical Industries Ltd (TEVA) earnings date, market-implied expected move, and options open interest by expiry

42.09

+0.62 · +1.50%

post 41.97 −0.29%

Closed19:06 ET

Open41.20Volume7.4MMkt cap$49.0BP/E67.69EPS0.62

Day40.85 – 42.4471%52-wk26.00 – 42.5996%

TEVA

Teva Pharmaceutical Industries Ltd

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±6.0%implied · report alone

8Q avg ±8.9%·×0.68·cheap

39.5544.63

straddle ±6.3%

spot 42.09exp Nov 6ATM strike 42ATM straddle 3.12IV 67%

Oct 30 closereport share · term structure

Expected move

Inputs

Next report

Nov 3

before open · in 3 days

confirmedQ3 FY26

Calendar

Next report

Last report

+9.60%

shaded = implied · ▲▼ = realized

Jul 29 '26 · confirmed

Implied vs realized

Largest filed tie

40.00%

of Alvotech revenue

supplierALVO 20-F

Supply chain

Largest filed tie

13F top-10 QoQ

—

Top fund weight

0.14%

TEVA weight · SEIE

N-PORTJun 30 '26

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Teva Pharmaceutical Industries (TEVA) reports on Nov 3 before open (confirmed date).

Implied vs realized

8 reports

—≥ implied

Jan 29 '25Jan 29 '25confirmed—▼−13.89%—

May 7 '25May 7 '25confirmed—▲+9.18%—

Jul 30 '25Jul 30 '25confirmed—▲+1.75%—

Nov 5 '25Nov 5 '25confirmed—▲+20.23%—

Jan 12 '26Jan 12 '26confirmed—▲+2.44%—

Jan 28 '26Jan 28 '26confirmed—▲+2.09%—

Q1 FY26Apr 29 '26confirmed—▲+11.89%—

Q2 FY26Jul 29 '26confirmed—▲+9.60%—

quarterimplied−25%0+25%realized×

Q2 FY26—▲+9.60%—

Q1 FY26—▲+11.89%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 9 expiries · Oct 29 close

0.32OI · 9 expiries · Oct 29 closeP/C open interest · Nov 6 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

500+28%Nov 66d1,562+2%

5220%Nov 1313d1.015160%1.01

4,224+1%Nov 2020d0.2615,9980%0.26

1210%Nov 2727d0.44278+1%0.44

20—Dec 434d0.2387—0.23

4 later expiries

0—Dec 1141d—0——

40,9920%Dec 1848d0.58

ExpiryPutsCallsP/C

Nov 66d500+28%1,562+2%0.32

Nov 1313d5220%5160%1.01

Nov 2020d4,224+1%15,9980%0.26

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±6.3%

Funds 2

SEIE±0.0%

VT±0.0%

Customers 1

SNY±1.0%×0.16

Dashed = straddle · × = co-movement · max 501dMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−13.88%as filednet margin · revenue +4.02% QoQ · −0.81% YoY

Revenue$4.1B+4.02%

Gross profit$2.2B51.98%+9.18%

Operating income−$231M−5.58%−135.43%

Pre-tax income−$455M−204.12%

Net income−$575M−13.88%−255.83%

Cost of revenue$2.0B−1.09%

Operating expenses$2.4B+80.74%

Tax$121M+80.60%

Other expense−$224M−3.70%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Oct 30 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:00 ET

Intraday

Event sensitivity

FOMC ×0.91· ±6.2% vs ±6.8% · 6 releases

eventrelease day|move|up · n×base

FOMCrate decision±6.2%2 of 6×0.91

Bar = avg |move| to ±7% · tick = ±6.8% avg day · ×base = |move| ÷ ±6.8% · min 6 releases

Earnings history

EPS -0.49 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Jul 29 '26 · confirmed	-0.49	—
Q1 FY26	Apr 29 '26 · confirmed	0.31	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod